Savitri Motaparthi, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 11050 Mount Belvedere Blvd, Usa Meddac /credentials, Fort Drum, NY 13602 Phone: 315-772-4025 Fax: 315-772-9498 |
Dr. Lara Kristina Primak, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 11050 Mt. Belvedere Blvd., Usa Meddac/credentials, Fort Drum, NY 13602 Phone: 315-772-4025 Fax: 315-772-9498 |
William Edwards, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Usa Meddac, 11050 Mount Belvedere Blvd, Fort Drum, NY 13602 Phone: 315-772-2778 |
Dr. Arthur Denning Duff, MD Pediatrics - Adolescent Medicine Medicare: Not Enrolled in Medicare Practice Location: 11050 Mount Belvedere Blvd, Attn: Credentials, Fort Drum, NY 13602 Phone: 315-772-4025 |
Dr. Carmelita Britton, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 11050 Mount Belvedere Blvd, Usa Meddac/credentials, Fort Drum, NY 13602 Phone: 315-772-4025 Fax: 315-772-9498 |
Diane Keating Jones, D.O Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 11050 Mount Belvedere Blvd, Family Practice Clinic, Fort Drum, NY 13602 Phone: 315-772-0859 |
News Archive
Gilead Sciences, Inc. and MicroDose Therapeutx, Inc. today announced that the companies have entered into an exclusive worldwide license and collaboration agreement for the development and commercialization of MDT-637, MicroDose's inhalable small molecule antiviral fusion inhibitor for the treatment of respiratory syncytial virus (RSV).
Researchers at Rensselaer Polytechnic Institute and University of North Carolina at Chapel Hill have discovered an alternative way to produce heparin, a drug commonly used to stop or prevent blood from clotting.
Children who have older brothers become more aggressive over time, on average, than those who have older sisters.
Street News Service/Inter Press Service examines how Senegal is addressing HIV/AIDS among prisoners in a Dakar maximum-security facility. "Prisons are high-risk environments for the transmission of the disease, due to the prevalence of hard drugs, violence and sexual relations," the news service writes and discusses how addressing such issues can present challenges in the majority-Muslim country.
ExonHit Therapeutics S.A. is pleased to announce that it has been chosen to participate in the European Innovative Medicines Initiative (IMI) consortium focused on identifying biomarkers for Alzheimer's disease (PharmaCog).
› Verified 4 days ago